<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: Medical Xpress news tagged with: immune dysfunction</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Ground breaking cancer research finds immune system link</title>
   	 <description>(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.</description>
	  <link>http://medicalxpress.com/news/2013-05-ground-cancer-immune-link.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 24 May 2013 08:20:01 EST</pubDate>
	 <guid isPermaLink="false">news288601940</guid>
	 
</item>
<item>
     <title>Liver cancers armed with many strategies for evading immune response</title>
   	 <description>(Medical Xpress)—Researchers at Roswell Park Cancer Institute (RPCI) have published findings that help explain how a common and particularly resilient form of liver cancer evades the body's natural antitumor responses. The study, published April 15 in the journal Cancer Research, a publication of the American Association for Cancer Research (AACR), is the first to examine the combined effect of immunosuppression on immune function in advanced hepatocellular carcinoma (HCC), the fifth-most-common cancer in the world and the third-leading cause of cancer-related mortality globally.</description>
	  <link>http://medicalxpress.com/news/2013-04-liver-cancers-armed-strategies-evading.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 18 Apr 2013 07:51:37 EST</pubDate>
	 <guid isPermaLink="false">news285490290</guid>
	 
</item>
<item>
     <title>FDA panel recommends against 1st drug for chronic fatigue syndrome</title>
   	 <description>(HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.</description>
	  <link>http://medicalxpress.com/news/2012-12-fda-panel-1st-drug-chronic_1.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 21 Dec 2012 10:40:42 EST</pubDate>
	 <guid isPermaLink="false">news275308835</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdapanelreco.jpg" width="90" height="90" />
</item>
<item>
     <title>FDA panel considers 1st drug for chronic fatigue syndrome</title>
   	 <description>(HealthDay)—A U.S. Food and Drug Administration advisory committee will meet Thursday to consider approval of the first drug to treat chronic fatigue syndrome.</description>
	  <link>http://medicalxpress.com/news/2012-12-fda-panel-1st-drug-chronic.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 20 Dec 2012 12:50:01 EST</pubDate>
	 <guid isPermaLink="false">news275229003</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/fdapanelcons.jpg" width="90" height="90" />
</item>
<item>
     <title>Are we closer to understanding the cause of deadly sepsis?</title>
   	 <description>Following an infection, dysregulation of the immune system can result in a systemic inflammatory response and an often fatal condition called severe sepsis or septic shock. Sepsis is not uncommon, yet its cause and underlying immune dysfunction remain poorly understood. Regulatory T cells (Tregs), a component of the immune system, now appear to have an important role in suppressing the immune response in advance of sepsis, and understanding this role may lead to new therapeutic strategies for improving patient outcomes, as described in a review article in Journal of Interferon &amp; Cytokine Research.</description>
	  <link>http://medicalxpress.com/news/2012-11-closer-deadly-sepsis.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 16 Nov 2012 12:56:11 EST</pubDate>
	 <guid isPermaLink="false">news272292918</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/areweclosert.jpg" width="90" height="90" />
</item>
<item>
     <title>Excessive ICU noise may harm patients</title>
   	 <description>New research shows that overnight noise levels in the medical ICU (MICU) often exceed recommended levels, which could potentially lead to worse outcomes.</description>
	  <link>http://medicalxpress.com/news/2012-10-excessive-icu-noise-patients.html</link>
	 <category>Health</category>
	 <pubDate>Mon, 22 Oct 2012 03:21:53 EST</pubDate>
	 <guid isPermaLink="false">news270094905</guid>
	 
</item>
<item>
     <title>Surprising results from smoke inhalation study</title>
   	 <description>A Loyola University Chicago Stritch School of Medicine study includes some unexpected findings about the immune systems of smoke-inhalation patients.</description>
	  <link>http://medicalxpress.com/news/2012-01-results-inhalation.html</link>
	 <category>Health</category>
	 <pubDate>Fri, 13 Jan 2012 12:20:01 EST</pubDate>
	 <guid isPermaLink="false">news245677426</guid>
	 
</item>
<item>
     <title>Early results link PTSD, compromised immune systems</title>
   	 <description>(Medical Xpress) -- Preliminary results of a study show a link between post-traumatic stress disorder (PTSD) and compromised immune system in war veterans diagnosed with PTSD.</description>
	  <link>http://medicalxpress.com/news/2011-07-early-results-link-ptsd-compromised.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 12 Jul 2011 08:15:19 EST</pubDate>
	 <guid isPermaLink="false">news229677263</guid>
	 
</item>


</channel>
</rss>
